Objective In 2024, the United States had the highest prevalence of psychedelic use recorded, but reliability of self-report data in surveys has not been rigorously assessed. Our objective was to quantify the reliability of self-report across 17 psychedelic and dissociative substances in an adult population sampled from the National Survey Investigating Hallucinogenic Trends (NSIHT). Methods In...
Mainstays of pharmacoepidemiology are large, representative, behavioral surveys, which focus on many drugs with few detailed behaviors. Smaller, targeted studies measure drug-specific patterns but without explicit generalizability assumptions; the evidence generated is narrow. In this cross-sectional survey study, we outline an estimation framework based on data fusion and combine two surveys:...
Psychedelic-assisted therapy could transform treating psychiatric illness, but harms from exacerbating substance use disorder (SUD) among adults with psychiatric illness using psychedelics have not been studied. A cross-sectional survey in the US was used to test whether Drug Abuse Screening Test scores (DAST-10, validated instrument predicting SUD) were more severe when psychiatric illnesses...